InvestorsHub Logo
Followers 7
Posts 504
Boards Moderated 0
Alias Born 06/02/2010

Re: None

Monday, 10/15/2018 5:31:45 PM

Monday, October 15, 2018 5:31:45 PM

Post# of 29669
Couple more notes of interest from the 10K "LA" is excited about!:

"more WOW

Property


We lease approximately 2,800 square feet of office space in Las Vegas, Nevada, pursuant to a lease that will expire on April 15, 2019. This facility serves as our corporate headquarters. We also lease approximately 1,777 square feet of office and production space, utilized by Irie, in Oakland, California, pursuant to a lease that will expire June 1, 2019. Our owned facility in Valencia, Spain includes: approximately 430,000 square feet of light deprivation greenhouse made with polished concrete and triple galvanized steel framework. This facility also has office space that the Company intends to utilize to house: (i) our Spanish Media department (lamarihuana.com), and (ii) a warehouse. The purchase also included outdoor space and the necessary structural steel sufficient to erect a new 64,000 sq. ft. galvanized steel frame facility the Company intends to build to use as a GMP extraction, formulation and bottling facility."

and this one I also find quite exciting!!!!!

"one more!

Research and Development


Freedom Leaf’s product lines are ready to jump to the next stage in developing products that we intend to be a step above the market. Our Leafceuticals Europe S.L.U. greenhouse property in Spain will concentrate on the development of new EU-registered strains of hemp that can be licensed to other farmers, as well as grown proprietarily for our own products. We will also develop clone technology to be able to sell farmers and agronomists new strains that are much easier to grow and provide properties that are beneficial to users of cannabinoid products.


We intend to expand our research staff over the next year to undertake the development through research of new health products, specifically concerning rare cannabinoids such as CBG, CBN, CBC, THCV, THCA, and more. Through proprietary research on these rare cannabinoids, we intend to develop novel and patentable medicinal products on a pharmaceutical-grade level.
"

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.